SCHEMBL265945

SCHEMBL265945

O=c1ccc(=O)n(-c2ccccc2)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
BLM P54132 1/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 2/20 0.48
MPI P34949 1/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
KDM4E B2RXH2 1/20 0.44
GAA P10253 2/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.42
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13562672 0.77 ALKBH5 (0.60) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL1232067 0.73 TSHR (0.48) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL3264283 0.72 ALDH1A1 (0.50) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL13860451 0.72 AURKA (0.57) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL31503514 0.72 MEN1 (0.50) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL27115574 0.72 LMNA (0.47) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL34121 0.72 ALDH1A1 (0.68) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL9150171 0.72 ALDH1A1 (0.68) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL3946801 0.72 MAPT (0.56) SMN1; SMN2LMNAALDH1A1POLBMAPT
SCHEMBL5425653 0.72 ALDH1A1 (0.68) SMN1; SMN2LMNAALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655070-B1 OXIDATION CATALYST ASAHI KASEI CHEMICALS CORP (JP) 2015-07-15 EP claimed
US-8133834-B2 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-03-13 US claimed
US-20100069670-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-03-18 US claimed
US-20060229471-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-10-12 US claimed
EP-1655070-A1 OXIDATION CATALYST Asahi Kasei Chemicals Corporation (JP) 2006-05-10 EP claimed
EP-1655070-B1 OXIDATION CATALYST ASAHI KASEI CHEMICALS CORP (JP) 2015-07-15 EP disclosed
US-8133834-B2 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-03-13 US disclosed
US-20100069670-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-03-18 US disclosed
US-20060229471-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-10-12 US disclosed
EP-1655070-A1 OXIDATION CATALYST Asahi Kasei Chemicals Corporation (JP) 2006-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069670-A1 Oxidation catalyst PPOX, SOD1, HAO2 SMN1; SMN2 4468/4885LMNA 4861/4885ALDH1A1 377/4885
US-20060229471-A1 Oxidation catalyst PPOX, SOD1, HAO2 SMN1; SMN2 4468/4885LMNA 4861/4885ALDH1A1 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.